You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

failed temozolomide

Showing 1 - 25 of 3,377
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma, Malignant Trial in Bangkok (ERC1671, GM-CSF, Cyclophosphamide)

Not yet recruiting
  • Glioma, Malignant
  • Bangkok, Vadhana, Thailand
    Bumrungrad International Hospital
May 9, 2022

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Metastatic Cancer Trial in Los Angeles (temozolomide)

Completed
  • Metastatic Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Glioma Trial in United States (Pembrolizumab, Olaparib and Temozolomide)

Recruiting
  • Glioma
  • Basking Ridge, New Jersey
  • +6 more
Apr 13, 2022

Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of

Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
Nov 12, 2019

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Liver Metastases
  • Capecitabine tablets + temozolomide tablets + SIR-Spheres
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Oct 1, 2021

Glioblastoma, Cancer of Brain and Nervous System, Glioblastoma Multiforme Trial in Stanford (Temozolomide, Stereotactic

Completed
Has Results
  • Glioblastoma
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Aug 4, 2021

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Newly Diagnosed High-Grade Glioma Trial in Baltimore (Mebendazole)

Completed
  • Newly Diagnosed High-Grade Glioma
  • Baltimore, Maryland
    The Johs Hopkins Hospital
May 6, 2021

Advanced Rectal Cancer Trial in Seoul (Capecitabine plus temozolomide VS Capecitabine)

Unknown status
  • Advanced Rectal Cancer
  • Capecitabine plus temozolomide VS Capecitabine
  • Seoul, Songpa, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Rectal Cancer Trial in Seoul (Temozolomide)

Completed
Has Results
  • Rectal Cancer
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

Recruiting
  • Newly Diagnosed Glioblastoma
  • SurVaxM
  • San Francisco, California
  • +9 more
Aug 23, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023